Nutex Health (NASDAQ:NUTX) Price Target Raised to $60.00

Nutex Health (NASDAQ:NUTX) had its price objective lifted by Benchmark from $45.00 to $60.00 in a research report released on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Separately, Maxim Group upped their price objective on Nutex Health from $45.00 to $50.00 and gave the company a “buy” rating in a research note on Tuesday.

Nutex Health Stock Performance

Nutex Health stock traded down $2.30 during trading hours on Tuesday, hitting $29.03. The stock had a trading volume of 14,616 shares, compared to its average volume of 42,590. The company has a 50-day moving average of $23.19 and a two-hundred day moving average of $13.95. The company has a quick ratio of 1.55, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. Nutex Health has a fifty-two week low of $4.16 and a fifty-two week high of $39.48. The company has a market cap of $157.92 million, a PE ratio of -3.09 and a beta of 0.11.

Insider Buying and Selling at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates purchased 1,350 shares of the stock in a transaction on Thursday, August 22nd. The stock was bought at an average cost of $21.46 per share, for a total transaction of $28,971.00. Following the completion of the acquisition, the chief financial officer now directly owns 2,277 shares of the company’s stock, valued at $48,864.42. The trade was a 145.63 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 38.52% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of NUTX. Essex Investment Management Co. LLC acquired a new stake in shares of Nutex Health in the 3rd quarter valued at approximately $1,579,000. Thompson Davis & CO. Inc. bought a new position in Nutex Health during the third quarter worth $494,000. Finally, International Assets Investment Management LLC bought a new position in shares of Nutex Health in the third quarter valued at about $188,000. 5.32% of the stock is owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.